VanEck Associates’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-49,943
Closed -$3.04M 1440
2024
Q3
$3.04M Sell
49,943
-2,808
-5% -$167K ﹤0.01% 816
2024
Q2
$3.07M Sell
52,751
-53,403
-50% -$2.74M ﹤0.01% 756
2024
Q1
$5.6M Buy
106,154
+22,166
+26% +$1.12M 0.01% 543
2023
Q4
$4.16M Sell
83,988
-5,410
-6% -$243K 0.01% 595
2023
Q3
$4M Buy
89,398
+14,710
+20% +$657K 0.01% 559
2023
Q2
$3.47M Buy
74,688
+17,122
+30% +$749K 0.01% 598
2023
Q1
$2.51M Buy
57,566
+10,587
+23% +$524K 0.01% 649
2022
Q4
$2.34M Sell
46,979
-3,033
-6% -$144K 0.01% 646
2022
Q3
$2.11M Sell
50,012
-3,239
-6% -$156K 0.01% 634
2022
Q2
$2.33M Buy
53,251
+8,433
+19% +$418K 0.01% 623
2022
Q1
$2.64M Buy
44,818
+4,607
+11% +$267K 0.01% 645
2021
Q4
$2.4M Buy
40,211
+8,989
+29% +$563K 0.01% 673
2021
Q3
$2.12M Buy
31,222
+2,650
+9% +$183K 0.01% 667
2021
Q2
$2.04M Buy
28,572
+5,890
+26% +$433K ﹤0.01% 664
2021
Q1
$1.53M Buy
22,682
+3,083
+16% +$210K ﹤0.01% 667
2020
Q4
$1.36M Buy
19,599
+336
+2% +$23K ﹤0.01% 613
2020
Q3
$1.22M Sell
19,263
-457
-2% -$28.1K ﹤0.01% 597
2020
Q2
$1.1M Sell
19,720
-371
-2% -$19.3K ﹤0.01% 599
2020
Q1
$976K Buy
20,091
+1,966
+11% +$116K 0.01% 576
2019
Q4
$1.16M Sell
18,125
-6,861
-27% -$406K ﹤0.01% 612
2019
Q3
$1.27M Sell
24,986
-2,168
-8% -$101K 0.01% 552
2019
Q2
$1.3M Buy
27,154
+5,148
+23% +$262K 0.01% 546
2019
Q1
$1.2M Buy
22,006
+1,016
+5% +$46K 0.01% 541
2018
Q4
$770K Buy
20,990
+6,836
+48% +$321K ﹤0.01% 581
2018
Q3
$831K Sell
14,154
-292,791
-95% -$18.7M ﹤0.01% 603
2018
Q2
$20M Sell
306,945
-230,059
-43% -$14.3M 0.09% 176
2018
Q1
$31.4M Buy
537,004
+49,690
+10% +$3.36M 0.16% 134
2017
Q4
$33.1M Buy
487,314
+47,047
+11% +$3.19M 0.16% 136
2017
Q3
$31.5M Buy
440,267
+66,082
+18% +$4.86M 0.16% 132
2017
Q2
$28.6M Buy
374,185
+28,594
+8% +$2.35M 0.16% 127
2017
Q1
$28.6M Buy
345,591
+44,327
+15% +$3.56M 0.13% 134
2016
Q4
$23.2M Buy
301,264
+70,530
+31% +$5.33M 0.12% 127
2016
Q3
$18.5M Buy
230,734
+38,567
+20% +$3.49M 0.09% 150
2016
Q2
$20M Buy
192,167
+179,228
+1,385% +$19.2M 0.1% 116
2016
Q1
$1.63M Buy
12,939
+728
+6% +$84.8K 0.01% 370
2015
Q4
$1.47M Buy
12,211
+1,535
+14% +$196K 0.01% 351
2015
Q3
$1.49M Sell
10,676
-1,144
-10% -$159K 0.01% 356
2015
Q2
$1.58M Buy
11,820
+327
+3% +$44.8K 0.01% 375
2015
Q1
$1.61M Sell
11,493
-835
-7% -$113K 0.01% 366
2014
Q4
$1.62M Sell
12,328
-1,757
-12% -$221K 0.01% 379
2014
Q3
$1.64M Sell
14,085
-3,462
-20% -$409K 0.01% 357
2014
Q2
$2.08M Buy
17,547
+173
+1% +$19.8K 0.01% 342
2014
Q1
$1.97M Buy
17,374
+468
+3% +$54.1K 0.01% 319
2013
Q4
$1.96M Buy
16,906
+655
+4% +$76.4K 0.01% 323
2013
Q3
$1.88M Buy
16,251
+933
+6% +$108K 0.01% 316
2013
Q2
$1.69M Buy
+15,318
New +$1.66M 0.01% 309

Other funds holding SRCL

VanEck Associates's SRCL Position: Q4 2024 in Review

VanEck Associates sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 49,943 shares — an estimated $3.04M sold.

VanEck Associates first reported a position in SRCL in Q2 2013 and held it in 46 quarters. The position peaked at $33.1M in Q4 2017. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • VanEck Associates reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • VanEck Associates sold 49,943 Stericycle Inc shares in Q4 2024, an estimated $3.04M.
  • VanEck Associates first reported a position in Stericycle Inc in Q2 2013 and held it in 46 quarters.
  • VanEck Associates's Stericycle Inc position peaked at $33.1M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.